Medical device-related infections cause undue patient distress, increased morbidity and mortality and pose a huge financial burden on healthcare services. The pathogens are frequently distributed heterogeneously in biofilms, which can persist without being effectively cleared by host immune defenses and antibiotic therapy. At present, there is no 'gold standard' available to reveal the presence of device-related biofilm infections. However, adequate sample collection and logistics, standardised diagnostic methods, and interpretation of results by experienced personnel are important steps in efficient diagnosis and treatment of these infections. The focus of this mini review is on prosthethic joint and cardiovascular implantable device infections, which exemplify permanent devices that are placed in a sterile body site. These device-related infections represent some of the most challenging in terms of both diagnosis and treatment.
Background
Implant surgery aims to secure or improve the patient's health and life-quality, but despite aseptic precautions and antibiotic prophylaxis during implantations, microbial infection still remains a problem. A complicating infection may have serious consequences for the individual patient, including removal of the implant, but may also lead to significant societal costs. Device-related infections prolong hospital stays and add billions of dollars each year to US health care system (1) . While up to 40% of hospital-acquired infections are attributed to catheter-associated urinary tract infections (CAUTI) alone (2) , several investigators (3-7) have reported an increasing incidence of prosthetic joint (hip and knee) infections (PJI), and cardiovascular implantable devices (CID) infections.
Device-related infection is mainly due to impaired host defense at the implant site and the formation of biofilm (a community of adherent microorganisms embedded within a self-produced matrix of extracellular polymeric substances) on the surface of the device (8) (9) (10) . Additionally, the location and type of the biomaterial influences the microbiological profile of infection. For example, vascular catheters, cerebrospinal fluid shunts, pacemaker electrodes, prosthetic joints, and cardiac valves are most often colonized by staphylococci, streptococci, enterococci, or Candida sp., whereas CAUTI are typically caused by enterococci and Enterobacteriaceae (11) .
In general, bacteria causing device-related infections primarily originate from bacteria on the patient's skin during implant insertion, followed by bacterial migration through incision channels to the device surface, or by hematogenous seeding (11) . Initial bacterial attachment is followed by the gradual development of biofilms, which is a primary virulence factor of bacteria involved in device-related infections. A key characteristic of these matrix-embedded bacterial communities is their tolerance to antibiotics and to host phagocytic defenses. In biofilms, poor penetration of many antibiotics, nutrient limitation, slow growth, adaptive stress responses, low metabolic activity, and the formation of persister cells are all hypothesized to contribute to a multifaceted microbial defense (12) (13) (14) (15) (16) (17) .
While there is widespread agreement that treating biofilm-associated infections as early as possible results more frequently in clinical resolution, early diagnosis is challenging. Bacteria in biofilms can persist without being effectively cleared by host immune defenses and the resulting indolent infection may not be detected by routine diagnostic procedures until the infection shows clinical signs and symptoms. Currently, antibiotic treatment along with removal of the device may represent the only effective treatment. Removal can be facile in the case of external catheters, or require surgery to remove non-adsorbable sutures or necrotic tissue. In the case of orthopedic hardware revision, removal may be quite invasive. In cases of prosthetic heart valves, pacemakers, or ventricular assist devices, infection may be life threatening.
The focus of this mini review is on PJI and CID infections, which exemplify permanent devices that are placed in a sterile body site. These are particularly challenging in terms of both diagnosis and treatment.
CURRENT DIAGNOSTIC PRACTICE
Generally, the standard practice for the microbiological diagnosis of device-related infection includes routine microbiological sampling consisting of culturing, identification, and antibiotic susceptibility tests. Although culture-based identification is key, there is no 'gold standard' for microbiological diagnosis of device-related infections. Protocols for the diagnosis and treatment of device-related infections are primarily based on convention and personal experience and therefore differ substantially between institutions and countries (18) . Furthermore, depending on the device in question, the microbiological diagnostic tests may differ widely. Table 1 illustrates infections associated with prosthetic joints and cardiovascular devices and the tests recommended for routine clinical microbiological diagnosis. Importantly, all of the recommended diagnostic tests are currently culture-based methods.
IMPROVING THE CURRENT DIAGNOSIS: CHALLENGES AND CONSIDERATIONS
To improve the success of microbiological diagnosis of device-related infections in our laboratories, we have found it necessary to evaluate and optimize each step in the process, from sampling to final microbial identification.
Specimens
The first step in accurate microbiological diagnosis of biofilm infections is to obtain representative samples from the infected site. Appropriate sample collection has been recognized as essential (26) . In 1981, Kamme & Lindberg reported the need for separate sampling and processing of multiple tissue biopsies (n = 5) taken in proximity to hip prostheses in order to achieve increased diagnosis accuracy (24) . Since then, several studies have documented the importance of multiple biopsies in improving diagnosis in PJI (21-23, 27, 28) , and this practice has become standard in many hospitals. Besides multiple tissue biopsies, the prosthesis itself (if removed) has been reported to be an important sample for diagnosis. Biofilm bacteria attached to the device surface can be dislodged upon vortexing, sonication, and vortexing, and subsequent culture of the sonicate has demonstrated increased sensitivity compared with tissue cultures alone (29) (30) (31) (32) . This is likely due to the larger sampling area (the entire surface of the prosthesis component) and the concentration of bacteria by centrifugation of sonicate (33) (34) (35) .
For each type of device, the best specimen set for infection diagnosis should be identified, as these infections may differ markedly from each other in terms of biomaterial, causative microorganism, anatomical location, and whether the device is external or internal. For example, in CAUTI the sonication technique has been evaluated in one study and shown to increase the detection of biofilms (36) . However, in the case of ureteral stents, sonication was found to be less sensitive than Maki's roll-plate technique, but more sensitive than culture of the urine sample alone (37) .
For infective endocarditis, sampling procedures for the heart valve (prosthesis) are well defined in international guidelines (19) , that is, requirement of how many sets of blood cultures in combination with other clinical data (modified Duke's criteria) (38) .
Sampling logistics
A direct consequence of obtaining multiple biopsies and different specimen types from the surgical field and depositing the specimens into different sample 290 transport kits is increased workload for the surgeon, who may have concerns and find the added procedures burdensome. Even with assistance from a skilled nurse, important samples can be missed or deposited in the wrong transport medium. This issue is most pronounced in the introductory phase of new sampling procedures or when a study involves multiple hospitals and healthcare workers. Therefore, it is extremely important to devise a workflow strategy that simplifies the standard operating procedures (SOP) for surgeons, nurses, and clinical microbiology staff, while also ensuring that a standardized and complete specimen set is obtained.
For PJI diagnosis, variation in sampling for standard microbiology has been shown to be critical for sensitivity and specificity (27) . To address this issue, an 'All in a box' concept was developed in the Danish PRIS project, where standardized prepacked sample boxes (39) were used to collect the entire range of specimens (in total 13 specimens per revision in addition to 5 periprosthetic tissue biopsies as a reference standard) with sample tubes containing appropriate transport medium for each specimen type taken during surgery for culture and molecular analysis. The surgical staff were also informed about the rationale for obtaining multiple specimens, and color-coded vials made specimen designation straightforward for correct handling. All in all, the standardized sampling procedures resulted in the completion of 89% of the cases in this research project, involving numerous orthopedic surgeons, nurses, and different hospital premises (39) . The 'All in a box' concept is applicable to diagnostic sampling of other device-related infections where SOPs are required for complex sample sets.
DIAGNOSTIC METHODS

Culture
Currently recommended diagnostic tests for devicerelated infections are all based on microbiological culture methods. The general advantages and disadvantages of culture are listed in Table 2 . While culture is a relatively simple method requiring standard equipment, skilled laboratory technicians are generally required for correct handling, cultivation, and final identification. The advantage of culture is that in spite of a low ratio of bacteria to human cells, detection levels evident by colonyforming units (CFUs) can be quite sensitive and reproducible. Conversely, prolonged incubation and multiple assessments of bacteriological media are time consuming. Moreover, despite clinical signs and symptoms or molecular diagnostic methods indicating the presence of bacteria, viable bacteria may not grow. Prior antibiotic treatment may also contribute to spuriously negative culture results (40, Staphylococcus aureus , coagulase-negative staphylococci, streptococci, enterococci, Candida spp.
Joint prosthesis
• Preoperative culture of aspirated synovial fluid can be useful which may be further improved by inoculation using blood culture bottles (21, 22) .
• Blood cultures for aerobic and anaerobic organisms should be obtained if a bloodstream infection is suspected (23).
• At least three and optimally five or six intraoperative tissue specimens should be sampled for culture before perioperative prophylaxis. Two or more intraoperative cultures or combination of preoperative aspiration and intraoperative cultures that yield the same organism may be considered definitive evidence of infection and differentiate from possible contamination (21) (22) (23) (24) . Extended incubation may improve sensitivity (21).
• Swab samples should be avoided (21, 22) .
• Sonication of the explanted device and culture of the sonication fluid increases the sensitivity (21-23).
S. aureus, Coagulase-negative staphylococci, streptococci (22, 25) 41). Specifically in the case of device-related infections, culture may be less effective for detecting bacteria in biofilms (42) .
To improve the sensitivity of culture in devicerelated infections, sonication of the removed device component (when possible) and subsequent culturing of the sonicate has been investigated in many device-related infections, including hip and knee (31, 34) , shoulder (29) , spine (30) , and cardiac implants (43) . Increased culture-positive results generally have been reported using sonication along with a shorter time-to-positivity compared with tissue biopsies (44) . A possible explanation may be due to the disruption of the cell wall/membrane, which initiates the transcription system for repair and thereby stimulates metabolically inactive or dormant cells in the biofilm and accelerates the growth of bacteria in biofilm (45) . In addition, the larger sampling area and concentration of the microorganisms before plating are responsible for the higher sensitivity of the technique. However, this comes with a higher risk of contamination, since the large surface of the prosthesis is exposed to air in the operating theatre. Furthermore, success may also depend on the bacterial strain.
The sonication fluid can also be used for inoculation into blood culture bottles (46, 47) . It has been shown that inoculation of sonication fluid in blood culture bottles is more sensitive than using standard media (as well as culture of tissue biopsies) particularly with regard to growth of fastidious bacteria and bacteria previously exposed to antibiotics (48, 49) .
The choice of culture media also has a significant impact on the recovery of bacteria. With multiple samples needed with different culture media and monitoring for up to 14 days, the daily clinical laboratory workflow can be time-consuming and arduous. A recent French prospective multicenter study evaluated the number of samples and culture media needed to diagnose PJI. The authors found that four periprosthetic tissue specimens (tissue, bone, or joint fluid) seeded in three culture media (a blood culture bottle, a chocolate agar plate, and Schaedler broth, and incubated for 5, 7, and 14 days, respectively) were sufficient for an accurate diagnosis of PJI, >98% with four specimens and 100% with three cultures for confirmed PJI (50) .
Prolonged incubation for up to 14 days has been shown to increase the proportion of positive samples and diversity of bacterial isolates in PJIs (51-53), likely due to slower growing clinical isolates or the lower metabolic activity of biofilm bacteria. Butler-Wu and coworkers showed a nearly 30% increase in cultures positive for Propionibacterium acnes when the incubation period for specimens from shoulder prosthesis infections was extended to 14 days (from the standard 7). However, Schwotzer et al. found no advantage of prolonged incubation of tissue biopsies from revision surgery (joint replacement and internal fixation devices) since 96.6% of the PJI cases were diagnosed within 7 days of incubation. Nevertheless, the authors agreed that prolonged incubation might be useful in situations in which the prevalence of slow-growing microorganisms and anaerobes is higher (54).
Culture-independent methods
In recent years, a variety of non-culture methods have been reported for the identification of pathogens causing device-related infections, such as biomarkers (55) , immunofluorescence microscopy (29, 56) , and nucleic acid-based molecular methods (44, 57, 58) . Much progress has been made, particularly in the field of PJI. Among these culture-independent methods, the development of nucleic acid (NA)-based methods is considered to play a central role in improving the detection and identification of microorganisms (42) . Although most of these molecular diagnostic methods have not yet become an integral part of clinical practice because of the current limitations associated with each method (Table 3) , these technologies offer valuable supportive data and promise significant progress toward etiological diagnosis. Multiplex PCR Multiplex PCR has been used successfully for PJIs in several studies and especially for patients receiving antibiotic treatment prior to surgery (62) (63) (64) (65) . For example, Cazanave et al. found it advantageous to combine broad-range primers and specific sets of primer pairs for the most common PJI bacteria like Staphylococci. The choice of target species for multiplex PCR assays is dependent on knowledge of the spectrum of bacteria previously linked to PJI, and therefore non-typical bacteria will not be detected by this diagnostic approach. However, this method is expedient and may additionally provide same-day diagnosis, making multiplex PCR diagnostics superior to bacteriological culture. Since multiplex PCR can use highly specific but short target sequences, the technique can be generally more sensitive than broad range PCR. Multiplex PCRs combining PCRs for different DNA targets, can be achieved by choosing primers for each target in such a way that different-sized amplicons for each target are produced. Optimization of such conventional multiplex PCRs is difficult however, since the efficiency of the PCR is correlated with the size of the amplicon, which can result in preferential amplification of smaller products. Thus, the detection limit of species in mixed infections may be difficult to determine.
DNA amplification based methods
Molecular techniques for the diagnosis of devicerelated infections have not yet become standard in
Broad-range 16S rRNA gene PCR followed by Sanger sequencing Detection of the 16S rRNA gene, a distinctive bacterial marker, and subsequent sequencing allows phylogenetic classification of bacteria based on heterogeneous rRNA-gene regions (66) . Previously, the step after amplification has either been cloning of 16S rRNA followed by Sanger sequencing (67) (68) (69) or direct Sanger sequencing eventually combined with a bioinformatics tool to calculate the probability of the presence of up to three bacterial species in a mixed chromatogram (RipSeq) if more than two bacterial species were present (68, 70).
Broad-range 16S rRNA gene PCR followed by next generation sequencing (NGS)
More recently, NGS-based methods have been widely used to study human microbiome, and 16S rRNA amplicon sequencing is commonly used to profile the bacterial diversity in a given sample. However, few studies using deep sequencing for implant infection diagnosis have been published. Compared with body sites with abundant bacteria, using deep sequencing from a normally sterile site (such as for PJI) for the detection of pathogens, raises a significant concern about contamination of the sample. In NGS, the background contamination profile has been shown to have an individual bacterial fingerprint for every laboratory and every molecular kit combination in use (71) . This issue is not problematic for specimens with high bacterial loads, since the target will outcompete less abundant contaminants in the initial PCR amplification step. However, for specimens with a very low amount of bacteria, contaminating DNA will become significant. It is therefore crucial to include appropriate negative controls from DNA extraction kits and PCR reagents for sequencing. On the other hand, one should also be aware of the detection limit of NGS, which is highly dependent on DNA extraction efficiency. Ryu et al. noticed the ratio of human DNA to bacterial DNA specifically being a problem when working with periprosthetic tissue specimens (65) . In these tissue specimens, the amount of bacterial DNA in the final DNA extract can be very low, due either to inefficient DNA extraction, or to the relative abundance of human DNA, leading to false negative results.
Therefore, to evaluate the efficiency of DNA extraction and the relative background abundance of human DNA in 16S amplicon sequencing in our laboratory, we directly compared the performance of two DNA extraction kits. More specifically, we extracted DNA from pure cultures of Salmonella bongori and Enterococcus phoeniculicola spiked with human tissue samples using DNeasy Blood & Tissue (Qiagen) and MolYsis TM Complete5 (Molzym). The strains were chosen because they never have been identified in human samples. With the first kit we observed intense smears from spiked cultures after broad-range 16S PCR, suggesting a clear influence of human DNA on PCR, while discrete PCR products of the correct size were obtained with the second kit in the presence of human tissue DNA Fig. 1 . We concluded that the DNA extracted with DNeasy Blood & Tissue kit was unsuitable for amplicon sequencing. On the other hand, amplicon sequencing of the DNA extracted with MolYsis TM Complete5 is shown in Fig. 2 and the results clearly indicate increasing amount of contaminating DNA in these data commensurate with the decreasing amount of bacteria. With the MolYsis TM Complete5 kit, the detection limit is around 600 CFU/ml compared with the detection of culture theoretically being 1 CFU/ml. However, this 1 CFU can also be a contaminant. This implies that in many cases culture-based methods may be better than NGS with respect to detection limit, cost, and hands-on time. Nevertheless, NGS may be especially useful in cases where culture remains negative in spite of clinical suspicion of infection, or where unusual or fastidious bacteria are suspected to be present. Thus, working with DNA amplification-based methods in routine microbiological laboratories not only requires specialized instruments but also specific laboratory prerequisites like appropriate workflow divisions and, most importantly, skilled personnel. Trained personnel need to take measures to control for inhibition of DNA amplification and to reduce the risk of contamination as much as possible (e.g., UTP prophylaxis) as well as the ability to troubleshoot and correctly interpret potential spurious results.
Other factors associated with NGS that may influence results, such as chimera formation of amplicons (72) and library preparation methodology may also be problematic (73) . Boers et al. nicely summarized the potential pitfalls in NGS-based microbiome study and urged everyone working with NGS data to be more critical (74) . Taken together, the use of NGS in the clinical diagnosis of infections requires the inclusion of appropriate controls and knowledge of the limitations or pitfalls of the chosen method for accurate interpretation of the data. On the other hand, the failure to accurately diagnose an infection may add to the already considerable costs of PJI and may be worth the expense.
Fluorescence in situ hybridization (FISH)
Since culture-and amplification-based methods require disintegration of the sample (and therefore disruption of any biofilms) and biofilm-specific diagnostic markers are lacking, to date microscopic techniques are the only methods that can differentiate between the presence of planktonic cells and biofilms. FISH is a technique that combines molecular detection of microorganisms with highly sensitive fluorescence microscopy and has been increasingly used for analysis of biofilm-associated infections. FISH uses fluorescently labeled oligonucleotide probes [DNA or peptide 'nucleic acid' (PNA)] that hybridize to their target sequence in fixed, morphologically intact cells. The most commonly used target in FISH for microbiological applications is the ribosomal RNA (rRNA) because it is highly abundant in active cells and allows the design of genus-specific or species-specific oligonucleotide probes for most bacteria, as well as for fungi or protozoa. Therefore, FISH allows culture-independent identification and simultaneously in situ visualization of bacteria. It complements culture and amplification techniques and adds spatial resolution to the data. This is particularly useful if FISH is applied to tissue sections.
However, the limitations of FISH include the need of invasive sampling, and the small sampling size (e.g., 2-lm sections instead of a whole prosthesis as used for sonication). Furthermore, interpretation of results is labor intensive and requires additional expertise, since autofluorescence as well as non-specific binding of the probes have to be carefully controlled. Therefore, the technique is not routine, but rather restricted to specialized laboratories and currently applicable for infections with a defined focus of interest, like endocarditis or cardiac devices or when culture or other techniques have repeatedly given a negative result while there is a high clinical suspicion of infection.
On the other hand, there remain several advantages for diagnostic labs as well as for research:
• Since FISH probes target rRNA, the signal intensity correlates with the ribosome content, indicative that the cells are active (presumably viable) at time of fixation (75) (76) (77) . Importantly, for endocarditis FISH-positive bacteria have been shown in culture negative samples due to the natural amplification of signal by the rRNA (78-82) (Fig. 3 ).
• The laboratory requirement for room workflow separation (as for NA amplification-based methods) is not necessary.
• The likelihood of contamination is low, since FISH visualizes the microorganisms within their histological context it can delineate between contamination and infection (Fig. 4) . This is in particular important for common contaminants from resident flora (e.g., skin flora like CNS or Propionibacterium spp.).
• FISH can demonstrate the localization of the bacteria and differentiate between invasive (deep tissue) or superficial infections and identify predilection sites on implants, which may be useful for understanding likely sites to examine devices for bacteria (83, 84) .
• Regarding mixed infections, FISH is able to assess the abundance of different species and identify the key species or invasive population.
• FISH can differentiate between single bacteria and microcolonies or extensive biofilms (Figs 5 and 6). Together with culture and NA amplification techniques, this has potential for a 'staging' of biofilm infections in the future and the development of specific therapeutic strategies for the different stages.
• PNA FISH is becoming more widespread in diagnostic labs with the advent of validated kits designed for high-throughput examination following blood culture. This approach may be useful in the case of specific microbial pathogens such as Staphylococcus aureus and in cases where a faster time to positivity is desirable (85) . This approach may also help to target appropriate antimicrobial therapy (86, 87) . Moreover, these authenticated protocols may allow for increased use of FISH probes in clinical labs that lack specific expertise. In addition, PNA probes have also been successfully used on tissue sections. 
RECOMMENDATIONS AND PERSPECTIVES
To diagnose, prevent, and treat biofilm infections, several excellent guidelines have been published, which take into account that a prominent lifestyle for microbial cells in device-related infections is in biofilms. For example, Høiby et al. convened an ESCMID guideline for the diagnosis and treatment of biofilm infections involving medical devices, as well as for some tissue-associated infections (88) . The Infectious Diseases Society of America has also published specific guidelines for intravascular catheter-related infections (89, 90) , catheter-associated urinary tract infection (2), and for PJI (23) . There are also recommendations for endocarditis and cardiovascular implantable electronic device infections (91, 92) , and ventilator-associated pneumonia (93) . It is not the intention of this mini review to repeat or summerize these published guidelines. Rather, we would like to add some considerations, which may improve the diagnosis: 1) Culture techniques will remain the mainstay for the diagnosis of device-related infections, as they are affordable and offer a non-a priori approach to the identification of causative organisms. 2) Given the importance of culture, there is a need to optimize: 
CONCLUSIONS
To improve the diagnosis of device-related biofilm infections, it is not only important to investigate the value of new diagnostic methods but also to reevaluate the fundamental approaches, including, the optimal specimen type or combination of samples, appropriate culture media, and growth conditions (e.g. time, temperature). As the microbiological profile of each device-related infection differs depending on the device location, device material, and surface characteristics, the optimal specimens and diagnostic methods will also vary and need to be defined separately. Therefore, more than one method may be needed when confronted with culture-negative results in the face of a strong clinical suspicion of infection. The key to an optimal diagnosis of device-related infections may therefore be a combination of several diagnostic tools on specified specimens that are interpreted alongside the individual patient history. Here, FISH may serve as a bridging technique between the disciplines because it stands uniquely between pathology, culturing, and molecular techniques. FISH is the only method that -in the truest sense of the word -looks at the infection in situ to diagnose a biofilm and is often able to put results obtained from other diagnostic tools into perspective. Consequently, it can be used for the staging of biofilm infections that may lead to therapy recommendations in the clinical routine.
Since the study of biofilm and device-related infections is a relatively young area of research, many unresolved questions remain regarding the in vivo pathogenesis and colonization strategy employed by diverse bacteria in biofilms. A better understanding of these essential aspects of biofilm infections at the molecular level, including specific virulence factors, will contribute to defining more suitable targets for therapeutic interventions, improved diagnosis as well as the development of new antibiofilm implant materials. With the fastpaced advancement of molecular methods, such as DNA sequencing, mass spectroscopy-based proteomics and metabolomics, it is now possible to study these details of infections in vivo. The resulting new knowledge will undoubtedly assist in understanding new targets in the fight against pathogens and the biofilm lifestyle in device-related infections.
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